AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The GLP-1 Dilemma: Accessibility and Ethics in Obesity Treatment
This chapter explores the complexities of GLP-1 drugs, focusing on their high costs and the ethical implications of insurance coverage. It compares international approaches to accessibility, highlighting disparities in coverage for diabetes and obesity treatment. Additionally, the chapter discusses the broader impact of healthcare policies, including the Affordable Care Act, on medication access and healthcare equity.